No Data
No Data
We Believe Yestar Healthcare Holdings' (HKG:2393) Earnings Are A Poor Guide For Its Profitability
YESTAR HEALTH: Interim report 2024
Yestar Health [02393] is now trading at HKD 0.046, a decrease of 11.54%.
As of 10:53, Yestar Health Holdings [02393] reported HK$0.046, down HK$0.006 or 11.54% from the previous closing price of HK$0.052. The turnover was HK$0.0093 million. The highest price today was HK$0.045, and the lowest price was HK$0.045. Based on yesterday's closing price, the 10-day average price is HK$0.05, and the 50-day average price is HK$0.05. The current P / E ratio is -7.27 times, and the 14-day relative strength index is 54.55.
YESTAR HEALTH: INTERIM RESULTS FOR SIX MONTHS ENDED 30 JUNE 2024
Yestar Health (02393.HK) expected significant growth in net profit in the mid-term.
Yestar Health (02393.HK) announced that compared with the unaudited comprehensive net profit of approximately RMB 11.6 million for the first six months ended June 30, 2023, the unaudited comprehensive net profit for the mid-term period during 2024 is expected to increase significantly by no less than RMB 1,050 million. The expected significant increase in the group's mid-term net profit mainly comes from (i) confirming substantial premiums due to the redemption of the preferred notes originally due in 2026 at a discount price, and (ii) reducing financial costs after redeeming the related preferred notes.
Yestar Health (02393) announces profit growth, with expected mid-term comprehensive net profit increase of no less than 1.05 billion yuan.
Yestar Health (02393) announced that the expected net profit for the first half of 2023 is approximately RMB 11.6 million, compared with the same period last year.
No Data
No Data